Swine (H1N1) flu has dipped this summer from peak levels in spring, but it has remained far more active than seasonal flu—especially in places where children and young people congregate, such as summer camps and military academies. Last week, the New York Times reported on steps camps are taking to protect children from swine flu, including providing the antiviral Tamiflu to all campers.
On Friday, officials from the Centers for Disease Control and Prevention sent a reminder that antiviral drugs approved for swine flu, including Tamiflu (oseltamivir) and Relenza (zanamivir), are recommended for the treatment of the flu—not typically for prevention. "There is a place for preventive use of these drugs, mainly for the very high-risk people who are in extremely close contact with someone with the virus," said Anne Schuchat, the Director of the National Center for Immunization and Respiratory Diseases. But camps and other institutions should generally focus on other more important prevention methods, such as separating the sick from others and encouraging hand washing and good hygiene.
Vaccine expected in October
There’s still a long way to go before there is a vaccine for swine flu, but so far the signs have been positive. Clinical trials have been planned, and this week a panel will convene to develop recommendations for which populations should be targeted, and what populations, if any, should be given priority. If all goes well officials expect to have a vaccine in October.
The flu season is still underway in the Southern Hemisphere, and swine flu is causing both mild and severe cases. The good news is that the virus does not appear to be mutating, or changing significantly, so the antigen in the vaccines would likely be effective.
—Kevin McCarthy, associate editor
Keep up to date with our Swine (H1N1) flu coverage and recommendations.












Previous









Post a comment
Comments: